论文部分内容阅读
目的探讨药物联合超短波辅助治疗小儿支气管肺炎的临床疗效。方法选取2012年1月至2014年5月我院儿科收治的支气管肺炎确诊患儿110例,随机分为试验组和对照组,各55例。对照组患儿给予抗感染、解痉及平喘等治疗措施和密切护理,在其基础上给予试验组患儿超短波理疗,治疗1周后比较两组患儿治疗前后血清免疫球蛋白IgG、IgA、IgM,细胞肿瘤坏死因子α(TNF-α)、白细胞介素-6(IL-6)水平变化及疗效差异。结果治疗后试验组患儿血清免疫球蛋白IgG、IgA、IgM升高幅度及细胞因子TNF-α、IL-6降低幅度均大于对照组,试验组患儿治疗总有效率优于对照组,差异均有统计学意义(P<0.05)。结论经药物联合超短波辅助治疗后,试验组患儿免疫功能恢复程度优于对照组,治疗效果明显。
Objective To investigate the clinical efficacy of drug combined with ultrashort wave in the treatment of pediatric bronchial pneumonia. Methods From January 2012 to May 2014, 110 children with bronchopneumonia diagnosed in pediatric department of our hospital were randomly divided into experimental group and control group, each with 55 cases. Control group of children given anti-infective, antispasmodic and asthma and other treatment measures and close care, on the basis of the experimental group of patients given ultrashort wave therapy, after 1 week of treatment compared two groups of children before and after treatment of serum immunoglobulin IgG, IgA , IgM, tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) Results After treatment, the increase of serum immunoglobulin IgG, IgA, IgM and the decrease of cytokines TNF-α and IL-6 in the experimental group were higher than those in the control group. The total effective rate of the experimental group was better than that of the control group All were statistically significant (P <0.05). Conclusion After the combination of drug and ultrashort wave adjuvant therapy, the recovery of immune function in the experimental group is better than that in the control group, and the treatment effect is obvious.